WEBINARS
Our webinars allow users to learn from experts and earn continuing education credits on industry topics, progress in research, services available, and more.
Show More
-
FEB 22, 2023 | 6:00 AM
Antibody-based therapeutics are helping patients across a wide range of disease areas, from cancer, such as Rituximab treatment of CD20-positive non-Hodgkin's lymphomas, to infectious di...
FEB 22, 2023 | 5:30 AM
G Protein Coupled Receptors (GPCRs) are therapeutic targets for many medications used to treat a variety of disease states. A large number of genetic variants have been identified in the gen...
FEB 22, 2023 | 5:30 AM
Many current technologies used in drug discovery and preclinical development programmes typically involve multi-step operations, extensive hands-on time, and lengthy liquid handling processe...
FEB 22, 2023 | 5:30 AM
Novel immunotherapy has revolutionized the landscape of cancer therapy in multiple tumor types since Ipilimumab, the first ICB agent, was approved for the treatment of metastatic melanoma is...
